ACM
RETA

Atika Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Atika Capital Management’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$2.24M Buy
2021
Q3 		– Sell
2021
Q2 		$6.79M Buy
2020
Q3 		– Sell
2020
Q2 		$10.7M Sell
2020
Q1 		$11.8M Buy
2019
Q4 		$12.8M Buy